March 25, 2025

New Oral Antibiotic Targets Uncomplicated UTIs

FDA approves gepotidacin, a first-in-class oral antibiotic, for treating uncomplicated urinary tract infections in females aged 12 and older, based on phase III trial results.

Conexiant

March 25, 2025

Researchers Question Routine Urodynamic Testing

The researchers found that invasive urodynamic testing did not improve outcomes or cost-effectiveness in women with refractory overactive bladder symptoms.

Conexiant

March 19, 2025

Study: Sex Differences in Physician Suicide

Researchers found that female physicians had a significantly higher suicide risk than female nonphysicians.

Conexiant

March 18, 2025

U.S. Fertility Rates Continue Decline; Age of Mothers Shifts

Maternal age distribution shifts dramatically as overall birth rates continue a 30-year decline, with women younger than 30 now accounting for less than half of all births, and an increase of older mothers.

Conexiant

March 14, 2025

HPV Vaccine Reduces Actinic Keratoses

VAXAK randomized trial demonstrates significant reduction in precancerous skin lesions following standard 9-valent alphapapillomavirus vaccination.

Conexiant

March 11, 2025

Doctors Never Truly Vacation, Study Reveals

"Organizations should implement strategies to minimize clinical tasks during PTO."

Conexiant

March 06, 2025

Tezepelumab Shows Promise for Severe CRSwNP in Phase 3 Trial

The WAYPOINT trial provides strong evidence that tezepelumab effectively reduces nasal polyp size, congestion, and overall symptom burden in patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps

Conexiant

March 06, 2025

An Estimated 31 Million Americans Borrowed for Medical Bills in 2024

A new West Health-Gallup Survey survey reveals insights into medical debt across all income levels and demographics in the United States.

Conexiant

March 06, 2025

Study: Treating Male Partners Cuts BV Recurrence

Clinical trial demonstrates combined oral and topical antimicrobial therapy for male partners reduces bacterial vaginosis recurrence by nearly half compared to standard female-only treatment, potentially changing clinical practice for a condition affecting 30% of reproductive-aged women worldwide.

Conexiant